Literature DB >> 20843908

Comparative analysis of disease activity measures, use of biologic agents, body mass index, radiographic features, and bone density in psoriatic arthritis and rheumatoid arthritis patients followed in a large U.S. disease registry.

Soumya M Reddy1, Allen P Anandarajah, Mark C Fisher, Philip J Mease, Jeffrey D Greenberg, Joel M Kremer, George Reed, Rui Chen, Susan Messing, Kimberly Kaukeinen, Christopher T Ritchlin.   

Abstract

OBJECTIVE: To compare disease activity, radiographic features, and bone density in psoriatic arthritis (PsA) and rheumatoid arthritis (RA) matched cohorts.
METHODS: Disease activity and radiographic data in the Consortium of Rheumatology Researchers of North America database from 2001 to 2008 were compared for 2481 patients with PsA and 17,107 patients with RA subsequently matched for age, gender, and disease duration. Radiographic outcomes included presence of erosions, and joint deformity. In addition, bone mineral density (BMD) scores for lumbar spine (L-spine) and femoral neck were compared using the same matching criteria plus weight and smoking status.
RESULTS: Tender (4.5 vs 3.4, p < 0.001) and swollen (4.4 vs 2.9, p < 0.012) joint counts, and modified Health Assessment Questionnaire scores were significantly higher (0.4 vs 0.3, p < 0.001) in patients with RA compared with patients with PsA. Patient general health and pain scores were also higher in patients with RA vs patients with PsA. Joint erosions (47.4% vs 37.6%, p = 0.020) and deformity (25.2% vs 21.6%, p = 0.021) were more prevalent in RA than PsA. In multivariate analysis, a reduced prevalence of erosions in PsA vs RA was noted (OR 0.609, p < 0.001). After matching, T-scores for L-spine (-0.54 vs -0.36, p = 0.077) and femoral neck (-0.88 vs -0.93, p = 0.643) were similar in patients with RA and patients with PsA, although body weight was a major confounder.
CONCLUSION: The level of disease activity and radiographic damage was significantly higher for RA vs PsA subjects, although the magnitude of differences was relatively small. BMD levels were comparable between cohorts. Outcomes in patients with PsA and patients with RA may be more similar than previously reported.

Entities:  

Mesh:

Year:  2010        PMID: 20843908     DOI: 10.3899/jrheum.100483

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  12 in total

Review 1.  Review of clinical registries of psoriatic arthritis: lessons learned?: value for the future?

Authors:  Dafna D Gladman; Vinod Chandran
Journal:  Curr Rheumatol Rep       Date:  2011-08       Impact factor: 4.592

2.  Density, structure, and strength of the distal radius in patients with psoriatic arthritis: the role of inflammation and cardiovascular risk factors.

Authors:  T Y Zhu; J F Griffith; L Qin; V W Y Hung; T-N Fong; S-K Au; A W Kwok; P-C Leung; E K Li; L-S Tam
Journal:  Osteoporos Int       Date:  2014-08-27       Impact factor: 4.507

3.  The risk of fracture among patients with psoriatic arthritis and psoriasis: a population-based study.

Authors:  Alexis Ogdie; Lauren Harter; Daniel Shin; Joshua Baker; Junko Takeshita; Hyon K Choi; Thorvardur Jon Love; Joel M Gelfand
Journal:  Ann Rheum Dis       Date:  2017-01-16       Impact factor: 19.103

Review 4.  Managing comorbid disease in patients with psoriatic arthritis.

Authors:  M Elaine Husni; Philip J Mease
Journal:  Curr Rheumatol Rep       Date:  2010-08       Impact factor: 4.592

5.  A comparison of the malignancy incidence among patients with psoriatic arthritis and patients with rheumatoid arthritis in a large US cohort.

Authors:  Rachael L Gross; Julie S Schwartzman-Morris; Michael Krathen; George Reed; Hong Chang; Katherine C Saunders; Mark C Fisher; Jeffrey D Greenberg; Chaim Putterman; Philip J Mease; Alice B Gottlieb; Joel M Kremer; Anna Broder
Journal:  Arthritis Rheumatol       Date:  2014-06       Impact factor: 10.995

Review 6.  Altered Bone Remodeling in Psoriatic Disease: New Insights and Future Directions.

Authors:  Ananta Paine; Christopher Ritchlin
Journal:  Calcif Tissue Int       Date:  2018-01-12       Impact factor: 4.333

7.  A comparison of disease burden in rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis.

Authors:  Brigitte Michelsen; Ragnhild Fiane; Andreas P Diamantopoulos; Dag Magnar Soldal; Inger Johanne W Hansen; Tuulikki Sokka; Arthur Kavanaugh; Glenn Haugeberg
Journal:  PLoS One       Date:  2015-04-08       Impact factor: 3.240

8.  Carotid plaque and bone density and microarchitecture in psoriatic arthritis: the correlation with soluble ST2.

Authors:  Jiayun Shen; Qing Shang; Chun-Kwok Wong; Edmund K Li; Emily W Kun; Isaac T Cheng; Martin Li; Tena K Li; Tracy Y Zhu; Cheuk-Man Yu; Ling Qin; Lai-Shan Tam
Journal:  Sci Rep       Date:  2016-08-24       Impact factor: 4.379

9.  Serum bone-turnover biomarkers are associated with the occurrence of peripheral and axial arthritis in psoriatic disease: a prospective cross-sectional comparative study.

Authors:  Deepak R Jadon; Raj Sengupta; Alison Nightingale; Hui Lu; Juliet Dunphy; Amelia Green; James T Elder; Rajan P Nair; Eleanor Korendowych; Mark A Lindsay; Neil J McHugh
Journal:  Arthritis Res Ther       Date:  2017-09-21       Impact factor: 5.156

10.  Osteoporosis in psoriatic arthritis: a cross-sectional study of an outpatient clinic population.

Authors:  Agnete Malm Gulati; Brigitte Michelsen; Andreas Diamantopoulos; Berit Grandaunet; Øyvind Salvesen; Arthur Kavanaugh; Mari Hoff; Glenn Haugeberg
Journal:  RMD Open       Date:  2018-06-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.